SGLT-2 inhibitors show mixed results after heart attack
While the composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack
Apr 8, 2024
0
0
While the composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack
Apr 8, 2024
0
0
About 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. There are limited treatments to prevent or slow that development.
Apr 8, 2024
0
0
For patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6 in Circulation to coincide with the ...
Apr 8, 2024
0
0
The common painkiller acetaminophen was found to alter proteins in the heart tissue when used regularly at moderate doses, according to a new study conducted in mice. Researchers presented their work at the American Physiology ...
Apr 8, 2024
0
2
New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs remain unproven five years later.
Apr 8, 2024
0
2
Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery topically rather than intravenously did not meet its primary endpoint of reducing seizures and was stopped early due to an increased ...
Apr 8, 2024
0
0
Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or "bad" cholesterol, levels ...
Apr 8, 2024
0
0
The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with evidence of improvements in symptoms and exercise capacity among people with nonobstructive hypertrophic cardiomyopathy (HCM), ...
Apr 8, 2024
0
0
A new study exploring the use of repeat antibiotic prescriptions for the same respiratory tract infection (RTI) episode—known as repeat 'within-episode' prescriptions—in primary care has found high rates of their use ...
Apr 8, 2024
0
0
Americans seem to have quite a positive view of dietary supplements. According to a 2023 survey, 74% of U.S. adults take vitamins, prebiotics and the like.
Apr 8, 2024
0
0